One of the more striking patterns in women's-health epidemiology is what happens to UTI rates after 45. A woman who's had perhaps one or two urinary-tract infections across her twenties and thirties will, somewhere in her late forties or early fifties, often start having them several times a year. The frequency tracks with the perimenopausal hormonal transition — and like most things in this domain, it has a clear biological explanation that's not widely shared.
Why UTI rates climb in midlife
Healthy reproductive-age vaginal flora — lactobacillus-dominant, low-pH — actually does double duty. The lactic acid that protects against vaginal opportunists also makes the local environment less hospitable for the gut bacteria (primarily E. coli) that cause most UTIs.
When perimenopause shifts the vaginal microbiome — less oestrogen, less glycogen, less lactobacillus, higher pH — that protective layer thins. E. coli and other gut-derived bacteria find it easier to colonise the vaginal environment first, and from there, easier to migrate to the urethra. The result is a meaningfully higher rate of recurrent UTI in women whose hormonal status has shifted, even when behaviour is unchanged.
This isn't speculation. It's been characterised in multiple cohort studies and explained mechanistically. It's also a pattern that responds well to a layered approach.
The layered approach
1. Restore the oestrogen environment (when appropriate)
Local vaginal oestrogen is the most effective single intervention for recurrent UTI in post-menopausal women. Multiple randomised trials have shown 50-75% reductions in UTI frequency with consistent local oestrogen use. This is well outside the territory of marginal effects.
For women whose primary concern is recurrent UTI, this is the first conversation to have with a clinician. Many GPs are still operating on outdated risk frames; if yours is hesitant, ask for a menopause-aware referral.
2. Restore the microbial environment
Targeted probiotic supplementation — strains specifically studied for vaginal flora, not generic gut probiotics — directly addresses the lactobacillus depletion. The mechanism is straightforward: more lactobacillus means more lactic acid, which means lower pH, which means a less hospitable environment for E. coli colonisation.
This is FloraGuard's role. The four strains in the formula — particularly the GR-1 and RC-14 combination — have specific published evidence for reducing recurrent UTI rates in midlife women.
3. Hydration and behavioural factors
Adequate fluid intake (2L+ daily, more in hot weather), urinating shortly after intercourse, wiping front-to-back, avoiding spermicides (which disrupt flora), avoiding harsh soaps, breathable underwear. These are well-established and cumulative — none is a heroic intervention, but they add up.
4. Cranberry — a cautious word
Cranberry products, in standardised proanthocyanidin (PAC) form, have modest evidence for reducing UTI frequency. Not as much as the marketing would suggest, but not zero either. The PAC content of generic cranberry juice is too variable to be relied upon; if you go this route, look for a standardised cranberry extract delivering 36mg+ of PAC daily.
Cranberry is not part of FloraGuard. We chose to keep the formula focused on the probiotic role, where the evidence is strongest, rather than diluting it with adjuncts whose role is more peripheral.
5. Talk to your GP about prophylactic antibiotics, but cautiously
For women with very frequent UTIs, low-dose prophylactic antibiotics are sometimes prescribed. These work in the short term but raise serious antibiotic-resistance concerns and tend to make the underlying microbiome problem worse rather than better. They're a tool of last resort, not a first-line intervention.
The pattern worth tracking
If you're a woman over 45 experiencing recurrent UTIs and you've been told it's "just one of those things" — it's not. There's a clear biological mechanism. There are clear, evidence-based interventions. And the trajectory you're on isn't fixed.
The combination of local oestrogen and targeted probiotic support, used consistently, reduces recurrent UTI frequency by substantial fractions in the published literature. The effect is real, the mechanism is clear, and the burden of proof for a clinician's "nothing to be done" is on them, not on you.
FloraGuard is designed for daily, ongoing use as part of a layered approach to vaginal microbiome support. For women whose primary symptom is recurrent UTI, the strain selection in FloraGuard — particularly the GR-1/RC-14 combination — has the strongest published evidence base. Most women see meaningful changes within 8-12 weeks of consistent daily use; the cumulative effect over 6+ months tends to be larger than the early-weeks effect.
The honest summary
Recurrent UTI in midlife women is a microbiome problem with a hormonal cause. The treatments that actually work — local oestrogen, targeted probiotics, sane lifestyle — are well-established and complementary. Antibiotics are useful for active infections but a poor long-term strategy.
If this is your situation, the layered approach is the one that holds up. Find a clinician who'll work through the layers with you.